These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Intravenous ferric saccharate therapy of iron deficiency anemia in gynecology]. STRAHM A; WALTER F Zentralbl Gynakol; 1951; 73(11):1011-5. PubMed ID: 14867649 [No Abstract] [Full Text] [Related]
3. [Colorimetric determination of iron in colloid iron-saccharate solutions]. OVERKAMP H Munch Med Wochenschr; 1952 Feb; 94(5):220-21. PubMed ID: 14919453 [No Abstract] [Full Text] [Related]
4. [Cooley's syndrome in the adult: treatment with intravenous iron saccharate]. MEGASSINI VE; MHANI NO Sem Med; 1950 May; 57(18):730-3. PubMed ID: 15418306 [No Abstract] [Full Text] [Related]
5. [Constitution of ferri-3-saccharate]. BERSIN T Pharm Acta Helv; 1951 Dec; 26(12):407-8. PubMed ID: 14941666 [No Abstract] [Full Text] [Related]
7. [Effect of experimental block of reticuloendothelial system with trypan blue and iron saccharate on anoxemic resistance in rat]. ARTETA JL; PUCHOL JR Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1954; 221(5):387-92. PubMed ID: 13185317 [No Abstract] [Full Text] [Related]
8. [On the problem of the effect of feeding of iron saccharate on the mutation rate induced by roentgen rays in Drosophila melanogaster]. TRAUT H Zh Vyssh Nerv Deiat Im I P Pavlova; 1960; 91():325-32. PubMed ID: 13777913 [No Abstract] [Full Text] [Related]
9. Use of i.v. iron saccharate in haemodialysis patients not responding to oral iron and erythropoietin. al-Hawas F; Abdalla AH; Popovich W; Mousa DH; al-Sulaiman MH; al-Khader AA Nephrol Dial Transplant; 1997 Dec; 12(12):2801-2. PubMed ID: 9430909 [No Abstract] [Full Text] [Related]
10. [Protective effect of the lysosomotrophic preparation rheopolyglucin in treating iron-deficient anemia with iron saccharate]. Ageeva TA; ShkurupiÄ VA Biull Eksp Biol Med; 1994 Jul; 118(7):40-3. PubMed ID: 7522618 [No Abstract] [Full Text] [Related]
11. Some effects of intravenous injections of saccharated iron oxide on serum iron and unsaturated iron binding capacity. CAMERON DG; BENSLEY EH; WOOD P Can Med Assoc J; 1951 Jan; 64(1):30-1. PubMed ID: 14792459 [No Abstract] [Full Text] [Related]
12. Intravenous ferric saccharate as an iron supplement in dialysis patients. Silverberg DS; Blum M; Peer G; Kaplan E; Iaina A Nephron; 1996; 72(3):413-7. PubMed ID: 8852489 [TBL] [Abstract][Full Text] [Related]
13. [The behavior of iron saccharates in the body and its therapeutic significance]. PRIBILLA W Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1953; 217(5):508-38. PubMed ID: 13087302 [No Abstract] [Full Text] [Related]
17. Toxic reactions after intravenous saccharated iron oxide in man; suggestions for improved preparations. NISSIM JA Br Med J; 1954 Feb; 1(4858):352-6. PubMed ID: 13115719 [No Abstract] [Full Text] [Related]
18. Preparation and standardization of saccharated iron oxide for intra venous administration. NISSIM JA; ROBSON JM Lancet; 1949 Apr; 1(6556):686-9. PubMed ID: 18118003 [No Abstract] [Full Text] [Related]
19. Experimental investigations on saccharated iron oxide. HAGBERG B; VAHLQUIST B; DICKIE W Acta Soc Med Ups; 1953; 58(1-2):73-82. PubMed ID: 13057653 [No Abstract] [Full Text] [Related]
20. [Problem of the blood pressure reduction by iron saccharates]. STILLE G; MEYER F Arzneimittelforschung; 1953 Mar; 3(3):145-7. PubMed ID: 13066365 [No Abstract] [Full Text] [Related] [Next] [New Search]